Trial Profile

A Prospective Observational Safety Study on Pregnancy Outcomes in Women Immunized With Afluria, a Seasonal Influenza Vaccine, During Pregnancy

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 14 Feb 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Influenza virus vaccine (Afluria) (Primary)
Indications Influenza virus infections
Focus Adverse reactions
Sponsors Seqirus

Most Recent Events

07 Feb 2022 Status changed from active, no longer recruiting to completed.
26 Aug 2021 Planned End Date changed from 16 Dec 2021 to 30 Sep 2021.
26 Aug 2021 Planned primary completion date changed from 16 Dec 2021 to 30 Sep 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com